Vagishwari Murugesan
Clinical Instructor
Boston University Chobanian & Avedisian School of Medicine
Dept of Medicine

favorite icon Linkedin

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kleytman N, Ruan J, Ruan A, Zhang B, Murugesan V, Lin H, Guo L, Klinger K, Mistry PK. Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease. Mol Genet Metab Rep. 2021 Dec; 29:100798. PMID: 34485083; PMCID: PMC8408524; DOI: 10.1016/j.ymgmr.2021.100798;
  2. James-Goulbourne T, Murugesan V, Kissin EY. Sonographic Features of Salivary Glands in Sjögren's Syndrome and its Mimics. Curr Rheumatol Rep. 2020 06 19; 22(8):36.View Related Profiles. PMID: 32562049
  3. Beshlawy AE, Murugesan V, Mistry PK, Eid K. Reversal of life-threatening hepatopulmonary syndrome in Gaucher disease by imiglucerase enzyme replacement therapy. Mol Genet Metab Rep. 2019 Sep; 20:100490. PMID: 31309038; PMCID: PMC6606832; DOI: 10.1016/j.ymgmr.2019.100490;
  4. Mandaliya R, Baig K, Barnhill M, Murugesan V, Som A, Mohammed U, Jhaveri K, Vangimalla SS, Raymond A, Tran J, Hasan L, Lewis JH, Cho W. Significant Variation in the Detection Rates of Proximal Serrated Polyps Among Academic Gastroenterologists, Community Gastroenterologists, and Colorectal Surgeons in a Single Tertiary Care Center. Dig Dis Sci. 2019 09; 64(9):2614-2621. PMID: 31152331; DOI: 10.1007/s10620-019-05664-w;
  5. Mirza M, Mirza M, Murugesan V, Olano A. Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis. Case Rep Gastrointest Med. 2018; 2018:4324592. PMID: 30533230; PMCID: PMC6247658; DOI: 10.1155/2018/4324592;
  6. Murugesan V, Liu J, Yang R, Lin H, Lischuk A, Pastores G, Zhang X, Chuang WL, Mistry PK. Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease. Blood Cells Mol Dis. 2018 02; 68:47-53. PMID: 28003098; PMCID: PMC5468511; DOI: 10.1016/j.bcmd.2016.12.002;
  7. Murugesan V, Chuang WL, Liu J, Lischuk A, Kacena K, Lin H, Pastores GM, Yang R, Keutzer J, Zhang K, Mistry PK. Glucosylsphingosine is a key biomarker of Gaucher disease. Am J Hematol. 2016 Nov; 91(11):1082-1089. PMID: 27441734; PMCID: PMC5234703; DOI: 10.1002/ajh.24491;
  8. Murugesan V, Lischuk A, Haims A, Lackman R, Brooks JS, Mankin H, Mistry PK. Case series and literature review of skeletal tumors and their incidence in the Gaucher disease population. Am J Hematol. 2016 07; 91(7):736-41. PMID: 27102845; DOI: 10.1002/ajh.24398;
  9. Braue J, Murugesan V, Holland S, Patel N, Naik E, Leiding J, Yacoub AT, Prieto-Granada CN, Greene JN. NF-?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria. Mediterr J Hematol Infect Dis. 2015; 7(1):e2015010. PMID: 25574369; PMCID: PMC4283928; DOI: 10.4084/MJHID.2015.010;
  10. Rajani AR, Mahmoud WE, Murugesan V, BinBrek AS. The mystery of recurrent idiopathic cerebrovascular and coronary arterial thrombosis. BMJ Case Rep. 2014 Nov 24; 2014. PMID: 25422328; PMCID: PMC4244328; DOI: 10.1136/bcr-2014-205430;
Showing 10 of 11 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 11 publications over 7 distinct years, with a maximum of 3 publications in 2016

Contact for Mentoring:

Murugesan's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department